Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
AbbVie Collaborates with Xilio Therapeutics on Tumor-Activated Immunotherapies
CompanyDeals

AbbVie Collaborates with Xilio Therapeutics on Tumor-Activated Immunotherapies

February 13, 2025
Astellas Pharma's Izervay Gets FDA Approval for GA Treatment Without Dosing Limit
CompanyDrug

Astellas Pharma’s Izervay Gets FDA Approval for GA Treatment Without Dosing Limit

February 13, 2025
Andon Health to Fully Control iHealth by Acquiring Best Ventures' Stake
CompanyDeals

Andon Health to Fully Control iHealth by Acquiring Best Ventures’ Stake

February 13, 2025
Hengrui Pharma's BD Head Dr. Chen Dong Departs for AbbVie's External Innovation Role
Company

Hengrui Pharma’s BD Head Dr. Chen Dong Departs for AbbVie’s External Innovation Role

February 13, 2025
Huadong Medicine's Biosimilar SaiYueXin Seeks NMPA Approval for Crohn's Disease
CompanyDrug

Huadong Medicine’s Biosimilar SaiYueXin Seeks NMPA Approval for Crohn’s Disease

February 13, 2025
J&J Innovative Medicine China Appoints New General Manager and Oncology VP
Company

J&J Innovative Medicine China Appoints New General Manager and Oncology VP

February 13, 2025
Liaoning Chengda Biotech to See Actual Controller Change of Controlling Shareholder
CompanyDeals

Liaoning Chengda Biotech to See Actual Controller Change of Controlling Shareholder

February 13, 2025
Bayer's Acoramidis (Beyonttra) Gets EMA Marketing Approval for ATTR-CM Treatment in EU
CompanyDrug

Bayer’s Acoramidis (Beyonttra) Gets EMA Marketing Approval for ATTR-CM Treatment in EU

February 13, 2025
Livzon's JP-1366 Injection Gets NMPA Green Light for Peptic Ulcer Bleeding Study
CompanyDrug

Livzon Pharmaceutical’s JP-1366 Approved for Peptic Ulcer Study by NMPA

February 13, 2025
Pfizer Partners with Alloy Therapeutics to Develop New Antibody Platform
CompanyDeals

Pfizer Partners with Alloy Therapeutics to Develop New Antibody Platform

February 13, 2025
Lifetech Scientific's Aortic Stent Graft System Wins NMPA Approval
CompanyMedical Device

Lifetech Scientific’s Aortic Stent Graft System Wins NMPA Approval

February 13, 2025
Eli Lilly Expands Collaboration with AdvanCell on Targeted Alpha Therapies for Cancer
CompanyDeals

Eli Lilly Expands Collaboration with AdvanCell on Targeted Alpha Therapies for Cancer

February 12, 2025
1 2 … 15 16 17 18 19 … 26 27
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up